Cardiovascular disease
Subtypes
Description
Cardiovascular disease develops primarily from metabolic dysfunction, inflammation, and damage to blood vessels—not from cholesterol alone. High carbohydrate intake and repeated insulin spikes drive insulin resistance, which elevates blood glucose, increases oxidative stress, and chronically inflames the arterial wall. This inflammation causes LDL particles to become trapped and oxidized beneath the endothelium, forming plaque. LDL itself is not inherently dangerous; what matters is the LDL-to-triglyceride ratio and particle size. High triglycerides create small, dense, oxidizable LDL particles that easily penetrate vessel walls. Low triglycerides (seen in ketosis) produce large, buoyant LDL that does not enter or inflame arteries. A heart attack or stroke occurs when unstable plaque ruptures or blood flow becomes critically restricted.
- Carbohydrates → Insulin spikes: drive fat storage, raise triglycerides, and promote small dense LDL formation.
- Insulin resistance: accelerates endothelial damage, inflammation, and plaque growth.
- Chronic inflammation: oxidizes LDL, stiffens arteries, and destabilizes plaques.
- High triglycerides: strongly correlate with arterial disease; low triglycerides predict healthy arteries.
Ketosis (from fasting, ketogenic diet, or carnivore diet) directly reverses the metabolic drivers of cardiovascular disease:
- Lowers insulin and restores insulin sensitivity.
- Drastically lowers triglycerides, improving LDL particle size and removing the dangerous small-dense LDL phenotype.
- Reduces systemic inflammation (IL-6, TNF-α), stabilizing arterial plaques.
- Improves HDL and lowers VLDL, reducing lipid deposition in arteries.
- Activates autophagy, which repairs endothelial damage and reduces plaque vulnerability.
The core problem is not LDL itself, but a high-carbohydrate, high-insulin, high-triglyceride metabolic state that drives inflammation and plaque oxidation. Ketosis creates the opposite metabolic environment—low triglycerides, low inflammation, stable LDL particles, and improved vascular integrity—making it protective against heart attack and stroke.
Root Causes
Treatment Options
[
11
] Benjamin D Horne et al. (2009)
DOI
PMCID
PMID
[
12
] Ciera L Bartholomew et al. (2021)
DOI
PMCID
PMID
[
13
] Celeste E Naude et al. (2022)
DOI
PMCID
PMID
[
14
] Kirubel T Hailu et al. (2024)
DOI
PMCID
PMID
[
15
] Sneha Annie Sebastian et al. (2024)
DOI
PMID
[
16
] Zhengqi Qiu et al. (2024)
DOI
PMCID
PMID
[
17
] Kelemu Tilahun Kibret et al. (2025)
DOI
PMCID
PMID
[
18
] Shaminie J Athinarayanan et al. (2020)
DOI
PMCID
PMID
[
19
] T Hu et al. (2015)
DOI
PMCID
PMID
[
20
] Thomas L Halton et al. (2006)
DOI
PMID
[
21
] Tingting Dong et al. (2020)
DOI
PMCID
PMID
[
22
] Parisa Ghasemi et al. (2024)
DOI
PMCID
PMID
[
13
] Celeste E Naude et al. (2022)
DOI
PMCID
PMID
[
23
] Oliver Hamer et al. (2023)
DOI
Sources
[1] Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality
[2] Dietary glycemic index, glycemic load, and risk of coronary heart disease, stroke, and stroke mortality: a systematic review with meta-analysis
[3] A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women
[4] Dietary dThe Burden of Carbohydrates in Health and Disease
[5] Insulin resistance is associated with increased risk of major cardiovascular events in patients with preexisting coronary artery disease
[6] Associations of Homeostatic Model Assessment for Insulin Resistance Trajectories With Cardiovascular Disease Incidence and Mortality
[7] The Canakinumab Antiinflammatory Thrombosis Outcome Study trial—the starting gun has fired
[8] Risk factors and prognostic value of endotoxemia in patients with acute myocardial infarction
[9] Trimethylamine N-oxide predicts cardiovascular events in coronary artery disease patients with diabetes mellitus: a prospective cohort study
[10] Increased intestinal mucosal permeability and metabolic endotoxemia predict the risk of cardiovascular mortality
[11] Usefulness of Routine Periodic Fasting to Lower Risk of Coronary Artery Disease among Patients Undergoing Coronary Angiography
[12] Randomized controlled trial of once-per-week intermittent fasting for health improvement: the WONDERFUL trial
[13] Low-carbohydrate versus balanced-carbohydrate diets for reducing weight and cardiovascular risk
[14] The Effect of Fasting on Cardiovascular Diseases: A Systematic Review
[15] Intermittent fasting and cardiovascular disease: A scoping review of the evidence
[16] Beneficial effects of time-restricted fasting on cardiovascular disease risk factors: a meta-analysis
[17] Intermittent Fasting for the Prevention of Cardiovascular Disease Risks: Systematic Review and Network Meta-Analysis
[18] Impact of a 2-year trial of nutritional ketosis on indices of cardiovascular disease risk in patients with type 2 diabetes
[19] The low-carbohydrate diet and cardiovascular risk factors: Evidence from epidemiologic studies
[20] Low-carbohydrate-diet score and the risk of coronary heart disease in women
[21] The effects of low-carbohydrate diets on cardiovascular risk factors: A meta-analysis
[22] Impact of very low carbohydrate ketogenic diets on cardiovascular risk factors among patients with type 2 diabetes; GRADE-assessed systematic review and meta-analysis of clinical trials
[23] Low-carbohydrate diets for reducing cardiovascular risk and supporting weight loss in adults: a synthesis of systematic reviews
[
23
] Oliver Hamer et al. (2023)
DOI